Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Company Information
About this company
Key people
Jose Ignacio Abia
Chief Executive Officer, Executive Director
Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Rahul Srinivasan
Chief Financial Officer
Jordi Balsells Valls
President - Plasma Procurement
Antonio Martinez Martinez
President - Diagnostic
Roland Wandeler
President - Biopharma
Camille Alpi
Chief Human Resources & Talent Officer
Lluis Pons Gomez
Senior Vice President - Strategy
Jaime Gonzalez
Chief Digital Information Officer
Joerg Schuettrumpf
Chief Scientific Innovation Officer
Anne-Catherine Berner
Independent Chairman of the Board
Tomas Daga Gelabert
Other External Director
Albert Grifols Coma-Cros
Proprietary Director
Victor Grifols Deu
Proprietary Director
Paul S. Herendeen
Proprietary Director
Click to see more
Key facts
- Shares in issue426.13m
- EPICGRFS
- ISINUS3984384087
- LocationSpain
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$7.79bn
- Employees23,833
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.